首页> 外文期刊>Infection and immunity >Enhancement and suppression by actinomycin D of a Vero cell nontransmissible measles infection.
【24h】

Enhancement and suppression by actinomycin D of a Vero cell nontransmissible measles infection.

机译:放线菌素D对Vero细胞不可传播的麻疹感染的增强和抑制作用。

获取原文
           

摘要

The effect of low doses of actinomycin D on Vero cell nontransmissible measles infection produced after cocultivation with a HeLa subline with persistent defective infection by Edmonston measles virus was examined by pretreatment of Vero cells with the drug and treatment at 1, 4, and 7 days after Vero cell infection. Pretreatment enhanced focal formation of viral immunofluorescent Vero cell syncytia but did not induce synthesis of detectable amounts od cocultures suppressed syncytial formation, and treatment of 4- and 7-day-old cocultures had little, if any, effect on syncytial formation. Pretreatment also eliminated a transient resistance to homologous superinfection. A possible relation of these findings to the presence of a cell-associated viral inhibitor in the persistently infected HeLa cells is discussed.
机译:通过用药物预处理Vero细胞并在治疗后第1、4和7天检查低剂量放线菌素D对与HeLa亚系共培养并伴有埃德蒙斯顿麻疹病毒持续性缺陷感染的Vero细胞不可传播的麻疹感染的影响Vero细胞感染。预处理可增强病毒免疫荧光Vero细胞合胞体的病灶形成,但不会诱导共培养物中可检测量的合成抑制合胞体形成,并且4天和7天大的共培养物对合胞体形成的影响很小(如果有的话)。预处理还消除了对同源重叠感染的短暂抵抗力。讨论了这些发现与持续感染的HeLa细胞中细胞相关病毒抑制剂的存在的可能关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号